Sanofi plans 466 job cuts as part of R&D reshuffle
Tweet
Share
E-mail
FILE PHOTO: The Sanofi logo at the Viva Tech start-up and technology summit in Paris, France, May 25, 2018. REUTERS/Charles Platiau/File Photo
PARIS (Reuters) - Sanofi on Wednesday said a reorganization of its research and development operation in Germany and France would result in 466 job cuts in the two countries.
In an emailed statement, a spokesman with the French drugmaker said the reshuffle aimed at enabling Sanofi to concentrate its research efforts in cancer, immunology, rare diseases and vaccines.
The company would end new research efforts in cardiology, the spokesman added, solely keeping existing research programs.
The 466 job cuts are to be implemented on a voluntary basis, Sanofi said. The company currently employs 15,000 in R&D worldwide out of a total staffing of more than 100,000.
(Reporting by Matthias Blamont; Editing by Leigh Thomas)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SpaceX held talks to acquire AI coding startup Cognition - report
- The new kingmakers: Crypto, AI and betting firms fuel record spending on the 2026 midterms
- Gains in AI company stakes juice second-quarter earnings for S&P 500
Create E-mail Alert Related Categories
General News, ReutersRelated Entities
LayoffsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
